Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
ACS in the Elderly
Author(s): Mansi Oberoi , Nitesh Ainani , J Dawn Abbott , et al Added: 1 year ago

MI/ACS
Author(s): Donald E Cutlip Added: 3 years ago
Stent thrombosis has been recognized as a serious complication of coronary stent placement since the procedure was first reported in the 1980s.1 Subsequent aggressive peri-procedural anti-thrombotic strategies with inpatient transition to warfarin reduced the risk to about 3.5 % for subacute (30-day) stent thrombosis,2,3 a rate that would be unacceptable by current standards and did not account… View more

Prevention & Chronic Conditions

Intervention
Author(s): Michela Faggioni , Michael C Gibson , Roxana Mehran Added: 3 years ago
The use of non-vitamin K antagonist oral anticoagulants (NVKA) has revolutionized the antithrombotic treatment of patients with atrial fibrillation (AF), finally freeing them of the inconvenience and expense of international normalized ratio measurements. However, add to the equation the presence of coronary artery disease requiring percutaneous coronary intervention (PCI) with stent placement… View more

Electrophysiology & Arrhythmia

Prevention & Chronic Conditions
Consultant Cardiologist Structural and Coronary Intervention Royal Papworth Hospital, Cambridge, UKClinical Director of Research and DevelopmentClinical Lead in Cardiovascular Disease – Cambridgeshire and Peterborough ICSNational Specialty Lead for Atherosclerosis and Cardiovascular Prevention NIHR CRN UKHonorary Senior Visiting Research Fellow – University of Cambridge View more
Author(s): Antonio Gutierrez , Sunil V Rao Added: 3 years ago
Current evidence-based therapies for ischemic heart disease include antithrombotic and antiplatelet medications that reduce the risk for ischemic outcomes such as myocardial infarction and stroke.1 Given their mechanism of action, bleeding is a risk with these agents, especially when combined with invasive procedures.2 In addition to overt bleeding, clinical trials of antithrombotic strategies… View more

Prevention & Chronic Conditions
Job title: Consultant Cardiologist, Bristol Heart Institute
Dr Johnson is fully trained in percutaneous coronary intervention and all aspects of general cardiology including hypertension, cardiovascular risk assessment, valvular heart disease, heart failure and arrhythmia. He qualified from St Mary's Hospital (Imperial College, London) in 1998 and prior to commencing specialist training in the South West he undertook a period of research studying novel… View more
Shao-Liang Chen
Research Area(s) / Expertise:
Dr Shao-Liang Chen is an interventional cardiologist at theNanjing First Hospital, Nanjing Medical University, Jiangsu Province, Nanjing, China. Dr Chen has published over 300 papers in peer-reviewed journals. Dr Chen's research interests include coronary intervention, pulmonary arterial hypertension and biological molecular science. Dr Shao-Liang Chen is Section Editor of European… View more